BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

836 related articles for article (PubMed ID: 30894512)

  • 21. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19.
    Ren J; Ding L; Zhang D; Shi G; Xu Q; Shen S; Wang Y; Wang T; Hou Y
    Theranostics; 2018; 8(14):3932-3948. PubMed ID: 30083271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long noncoding RNAs in triple-negative breast cancer: A new frontier in the regulation of tumorigenesis.
    Thakur KK; Kumar A; Banik K; Verma E; Khatoon E; Harsha C; Sethi G; Gupta SC; Kunnumakkara AB
    J Cell Physiol; 2021 Dec; 236(12):7938-7965. PubMed ID: 34105151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The long non-coding RNA landscape in triple-negative breast cancer.
    Zhang W; Guan X; Tang J
    Cell Prolif; 2021 Feb; 54(2):e12966. PubMed ID: 33314471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. lncRNA LUCAT1/ELAVL1/LIN28B/SOX2 Positive Feedback Loop Promotes Cell Stemness in Triple-Negative Breast Cancer.
    Xia L; Wang H
    Breast J; 2022; 2022():7689718. PubMed ID: 35711895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Up-regulated lncRNA GAS5 promotes chemosensitivity and apoptosis of triple-negative breast cancer cells.
    Li J; Li L; Yuan H; Huang XW; Xiang T; Dai S
    Cell Cycle; 2019 Aug; 18(16):1965-1975. PubMed ID: 31282278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NOTCH4 maintains quiescent mesenchymal-like breast cancer stem cells via transcriptionally activating SLUG and GAS1 in triple-negative breast cancer.
    Zhou L; Wang D; Sheng D; Xu J; Chen W; Qin Y; Du R; Yang X; He X; Xie N; Liu S; Zhang L
    Theranostics; 2020; 10(5):2405-2421. PubMed ID: 32104513
    [No Abstract]   [Full Text] [Related]  

  • 27. Long non-coding RNA HUMT hypomethylation promotes lymphangiogenesis and metastasis via activating FOXK1 transcription in triple-negative breast cancer.
    Zheng S; Yang L; Zou Y; Liang JY; Liu P; Gao G; Yang A; Tang H; Xie X
    J Hematol Oncol; 2020 Mar; 13(1):17. PubMed ID: 32138762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockdown of the oncogene lncRNA NEAT1 restores the availability of
    Hu Y; Yang Q; Wang L; Wang S; Sun F; Xu D; Jiang J
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29654165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocellular Carcinoma and Nuclear Paraspeckles: Induction in Chemoresistance and Prediction for Poor Survival.
    Kessler SM; Hosseini K; Hussein UK; Kim KM; List M; Schultheiß CS; Schulz MH; Laggai S; Jang KY; Kiemer AK
    Cell Physiol Biochem; 2019; 52(4):787-801. PubMed ID: 30946555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N6-methyladenosine reader hnRNPA2B1 recognizes and stabilizes NEAT1 to confer chemoresistance in gastric cancer.
    Wang J; Zhang J; Liu H; Meng L; Gao X; Zhao Y; Wang C; Gao X; Fan A; Cao T; Fan D; Zhao X; Lu Y
    Cancer Commun (Lond); 2024 Apr; 44(4):469-490. PubMed ID: 38512764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knockdown of lncRNA H19 restores chemo-sensitivity in paclitaxel-resistant triple-negative breast cancer through triggering apoptosis and regulating Akt signaling pathway.
    Han J; Han B; Wu X; Hao J; Dong X; Shen Q; Pang H
    Toxicol Appl Pharmacol; 2018 Nov; 359():55-61. PubMed ID: 30244121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p.
    Wang L; Luan T; Zhou S; Lin J; Yang Y; Liu W; Tong X; Jiang W
    Cancer Med; 2019 Aug; 8(9):4389-4403. PubMed ID: 31215169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA ZEB2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2.
    Zhang G; Li H; Sun R; Li P; Yang Z; Liu Y; Wang Z; Yang Y; Yin C
    J Cell Mol Med; 2019 May; 23(5):3271-3279. PubMed ID: 30825262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA NEAT1 promotes the tumorigenesis of colorectal cancer by sponging miR-193a-3p.
    Yu HM; Wang C; Yuan Z; Chen GL; Ye T; Yang BW
    Cell Prolif; 2019 Jan; 52(1):e12526. PubMed ID: 30407674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A feedback loop between lncRNA MALAT1 and DNMT1 promotes triple-negative breast cancer stemness and tumorigenesis.
    Hu Y; He Y; Luo N; Li X; Guo L; Zhang K
    Cancer Biol Ther; 2023 Dec; 24(1):2235768. PubMed ID: 37548553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microenvironmental Regulation of Long Noncoding RNA LINC01133 Promotes Cancer Stem Cell-Like Phenotypic Traits in Triple-Negative Breast Cancers.
    Tu Z; Schmöllerl J; Cuiffo BG; Karnoub AE
    Stem Cells; 2019 Oct; 37(10):1281-1292. PubMed ID: 31283068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proliferation-associated long noncoding RNA, TMPO-AS1, is a potential therapeutic target for triple-negative breast cancer.
    Mitobe Y; Ikeda K; Sato W; Kodama Y; Naito M; Gotoh N; Miyata K; Kataoka K; Sasaki H; Horie-Inoue K; Inoue S
    Cancer Sci; 2020 Jul; 111(7):2440-2450. PubMed ID: 32437068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-155 increases stemness and decitabine resistance in triple-negative breast cancer cells by inhibiting TSPAN5.
    Yang LW; Wu XJ; Liang Y; Ye GQ; Che YC; Wu XZ; Zhu XJ; Fan HL; Fan XP; Xu JF
    Mol Carcinog; 2020 Apr; 59(4):447-461. PubMed ID: 32096299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA DGCR5 incudes tumorigenesis of triple-negative breast cancer by affecting Wnt/β-catenin signaling pathway.
    Jiang D; Wang C; He J
    J BUON; 2020; 25(2):702-708. PubMed ID: 32521856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NEAT1_2 functions as a competing endogenous RNA to regulate ATAD2 expression by sponging microRNA-106b-5p in papillary thyroid cancer.
    Sun W; Lan X; Zhang H; Wang Z; Dong W; He L; Zhang T; Zhang P; Liu J; Qin Y
    Cell Death Dis; 2018 Mar; 9(3):380. PubMed ID: 29515109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.